Valuation: China Resources Double-Crane Pharmaceutical Co.,Ltd.

Market Cap 16.77B 2.5B 2.2B 2.09B 1.88B 3.55B 240B 3.6B 24.96B 9.61B 123B 9.39B 9.18B 393B P/E 2026 *
9.5x
P/E 2027 * 8.87x
Enterprise Value 16.77B 2.5B 2.2B 2.09B 1.88B 3.55B 240B 3.6B 24.96B 9.61B 123B 9.39B 9.18B 393B EV / Sales 2026 *
1.47x
EV / Sales 2027 * 1.4x
Free-Float
37.31%
Yield 2026 *
3.14%
Yield 2027 * 3.26%
1 day+2.01%
1 week+0.87%
Current month+1.00%
1 month+0.50%
3 months-2.58%
6 months-12.17%
Current year-11.21%
1 week 15.86
Extreme 15.86
16.28
1 month 15.72
Extreme 15.72
16.31
Current year 15.29
Extreme 15.29
19.08
1 year 15.29
Extreme 15.29
19.77
3 years 14.8
Extreme 14.8
26.15
5 years 11.25
Extreme 11.25
37.44
10 years 10.66
Extreme 10.66
37.44
Manager TitleAgeSince
Director of Finance/CFO 43 17/02/2025
President 45 24/10/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 67 11/07/2021
Director/Board Member 68 29/05/2006
Chairman 50 20/09/2023
Date Insider Type Main position Quantity % Market Cap. Importance
21/12/22 Buy

Chairman

5,000 0.0005%
21/12/22 Buy

Director

10,000 0.0010%
20/12/22 Buy

Director

5,000 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+2.01%+0.87%-13.02%-6.99% 2.45B
-1.71%+1.51%+53.13%+117.05% 1,056B
-0.76%-1.21%+43.42%+71.40% 645B
-0.13%-0.73%+13.65%+77.50% 465B
-2.12%-1.42%+73.92%+42.34% 368B
-0.06%-3.88%+34.32%+40.74% 335B
-0.79%+2.01%+19.82%+28.48% 275B
-1.19%-1.21%+9.82%+12.15% 255B
-0.36%+3.83%+49.42%+58.33% 229B
-0.98%-0.79%+35.30%+102.67% 188B
Average -0.57%+0.24%+31.98%+54.37% 381.82B
Weighted average by Cap. -1.02%+0.30%+40.60%+72.93%

Financials

2026 *2027 *
Net sales 11.39B 1.7B 1.5B 1.42B 1.28B 2.41B 163B 2.44B 16.95B 6.52B 83.25B 6.38B 6.24B 267B 11.98B 1.79B 1.57B 1.49B 1.34B 2.53B 171B 2.57B 17.82B 6.86B 87.52B 6.7B 6.56B 281B
Net income 1.78B 265M 233M 221M 199M 376M 25.39B 381M 2.64B 1.02B 12.98B 994M 973M 41.61B 1.9B 283M 249M 236M 213M 402M 27.16B 407M 2.83B 1.09B 13.88B 1.06B 1.04B 44.51B
Net Debt - -
Logo China Resources Double-Crane Pharmaceutical Co.,Ltd.
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based company primarily engaged in the new drug research and development, preparation production, drug sales, and active pharmaceutical ingredients (API) production. The Company operates two segments. The Infusion segment is mainly engaged in the production and sale of infusion products and the provision of services. The Non-Infusion segment is mainly engaged in the production and sale of non-infusion products and the provision of services. The Company's chronic disease business products include compound reserpine triamterene tablets, gliquidone tablets and others. The Company's specialty business products include teniposide injection, busulfan injection and others. The Company's infusion business products include basic infusion, therapeutic infusion, nutritional infusion and other multi-category infusion products. The Company's API business products include valsartan, amlodipine, pregabalin and others.
Employees
13,184
Date Price Change Volume
29/09/26 CN¥16.24 +2.01% 8,632,253
29/09/26 CN¥15.92 -0.38% 3,797,688
28/09/26 CN¥15.98 -0.44% 4,513,485
24/09/26 CN¥16.05 +0.12% 5,035,996
23/09/26 CN¥16.03 -0.43% 4,611,784
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.24CNY
Average target price
24.30CNY
Spread / Average Target
+49.63%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600062 Stock